SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): June 1, 2016


REJUVEL BIO-SCIENCES, INC.

(Exact name of Company as specified in its charter)


Florida

0-53698

27-1116025

(State or other jurisdiction

(Commission File Number)

(IRS Employer

of Incorporation)

 

Identification Number)

 


Chase Bank Building

150 SE 2nd Ave, Suite 403

Miami, Florida 33131

 

 

(Address of principal executive offices)

 

 


Phone: (800) 670-0448

 

 

(Company’s Telephone Number)

 



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:


[   ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


[   ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


[   ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


[   ]    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 5.02 – DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS


On June 1, 2016, Rejuvel Bio-Sciences, Inc., a Florida corporation, (the “Company”), with the approval of its board of directors and its majority shareholders by written consent in lieu of a meeting, removed Mr. John T. Stickler, as a Director and officer of the Company and terminated his Consulting Agreement.



 



SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



                                                             Rejuvel Bio-Sciences, Inc.


Date: June 1, 2016

By: /s/ Charles J. Scimeca

Charles J. Scimeca

President and CEO




Rejuvel Bio Sciences (CE) (USOTC:NUUU)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Rejuvel Bio Sciences (CE) 차트를 더 보려면 여기를 클릭.
Rejuvel Bio Sciences (CE) (USOTC:NUUU)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Rejuvel Bio Sciences (CE) 차트를 더 보려면 여기를 클릭.